Feasibility of Assessing Cryoballoon Pulmonary Vein Occlusion With Saline Injection and a Novel Mapping System.


Journal

JACC. Clinical electrophysiology
ISSN: 2405-5018
Titre abrégé: JACC Clin Electrophysiol
Pays: United States
ID NLM: 101656995

Informations de publication

Date de publication:
06 2022
Historique:
received: 04 01 2022
revised: 13 04 2022
accepted: 15 04 2022
entrez: 23 6 2022
pubmed: 24 6 2022
medline: 28 6 2022
Statut: ppublish

Résumé

Thirty-eight patients had assessment of pulmonary vein occlusion with the dielectric mapping system and injection of saline as an alternative to contrast. Contrast injection was required to ascertain pulmonary vein occlusion in 31.6% (12 of 38) of subjects and 17.4% (27 of 155) of veins. No contrast was required in the last 13 subjects. In this single center study, a novel mapping-guided cryoablation approach appeared to minimize the use of contrast in pulmonary vein isolation for the treatment of atrial fibrillation.

Identifiants

pubmed: 35738857
pii: S2405-500X(22)00332-2
doi: 10.1016/j.jacep.2022.04.011
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

795-799

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures Drs Houmsse and Daoud have received research support from Medtronic. Dr Sulkin, Mr Tomaszewski, Dr Shulepov, and Mr Glassner are salaried employees of EPD Solutions. Drs Hummel and Augostini have received consulting fees from EPD Solutions and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Mahmoud Houmsse (M)

Wexner Medical Center, Ohio State University, Columbus, Ohio, USA. Electronic address: mahmoud.houmsse@osumc.edu.

Faisal Matto (F)

Wexner Medical Center, Ohio State University, Columbus, Ohio, USA.

Matthew S Sulkin (MS)

EPD Solutions, Best, the Netherlands.

David J Tomaszewski (DJ)

EPD Solutions, Best, the Netherlands.

Sergei Shulepov (S)

EPD Solutions, Best, the Netherlands.

Lior Glassner (L)

EPD Solutions, Best, the Netherlands.

Ralph Augostini (R)

Wexner Medical Center, Ohio State University, Columbus, Ohio, USA.

Steven Kalbfleisch (S)

Wexner Medical Center, Ohio State University, Columbus, Ohio, USA.

Emile G Daoud (EG)

Wexner Medical Center, Ohio State University, Columbus, Ohio, USA.

John Hummel (J)

Wexner Medical Center, Ohio State University, Columbus, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH